Search results
Results From The WOW.Com Content Network
Schilder disease or diffuse myelinoclastic sclerosis: is a rare disease that presents clinically as a pseudotumoural demyelinating lesion; and is more common in children. [56] [57] Solitary sclerosis: This variant was proposed (2012) by Mayo Clinic researchers. [58] though it was also reported by other groups more or less at the same time.
Central pontine myelinolysis is a neurological condition involving severe damage to the myelin sheath of nerve cells in the pons (an area of the brainstem). It is predominately iatrogenic (treatment-induced), and is characterized by acute paralysis, dysphagia (difficulty swallowing), dysarthria (difficulty speaking), and other neurological symptoms.
Because pachygyria is a structural defect no treatments are currently available other than symptomatic treatments, especially for associated seizures. Another common treatment is a gastrostomy (insertion of a feeding tube) to reduce possible poor nutrition and repeated aspiration pneumonia. [4]
Encephalopathy is a difficult term because it can be used to denote either a disease or finding (i.e., an observable sign in a person). [citation needed] When referring to a finding, encephalopathy refers to permanent (or degenerative) [11] brain injury, or a reversible one. It can be due to direct injury to the brain, or illness remote from ...
In children, the most common cause is a stroke of the ventral pons. [9]Unlike persistent vegetative state, in which the upper portions of the brain are damaged and the lower portions are spared, locked-in syndrome is essentially the opposite, caused by damage to specific portions of the lower brain and brainstem, with no damage to the upper brain.
These disorders affect the brain, spinal cord, and nerve networks, presenting unique diagnosis, treatment, and patient care challenges. At their core, they represent disruptions to the intricate communication systems within the nervous system , stemming from genetic predispositions, environmental factors, infections, structural abnormalities ...
Pharmacological methods of treatment include fludrocortisone, midodrine, somatostatin, erythropoietin, and other vasopressor agents. However, often a patient with pure autonomic failure can mitigate his or her symptoms with far less costly means.
The exact pathophysiological causes of the disease are currently unclear, but there are developing theories. [8] Spongy degeneration can be diagnosed with neuroimaging techniques and urine examination. [9] There is no current treatment for spongy degeneration, but research utilising gene therapy to treat the disease is underway. [8]